drugset / Trial / NCT00579553
Comparing IM vs. Vaginal Progesterone for Pre-term Birth
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized controlled trial comparing weekly intramuscular injection of 17 alpha hydroxylprogesterone caproate with daily vaginal progesterone in women with singleton pregnancies and history of prior spontaneous preterm birth in terms of maternal, fetal and neonatal outcomes. Our aim is to assess the effects on maternal, fetal and neonatal outcomes of antenatal progesterone administered intramuscularly versus vaginally in women with singleton pregnancy and a history of prior preterm birth.
Timeline
- Start
- 2006-10
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 17-alpha-hydroxyprogesterone caproate | Unknown | 250 mg | Intramuscular |
| Subject | Progesterone | Other / unclassified | 100 mg | Intravenous |
Indications
No indication recorded.